ICD-10-CM Billable Code

C82.80

Other types of follicular lymphoma, unspecified site

Clinical Classification Guidelines

Medical Intelligence & Overview

Follicular lymphoma is a type of blood cancer that begins in the lymphatic system, which is part of the body's immune system. It develops from abnormal B-lymphocytes, or B-cells, which are a kind of white blood cell. When the disease affects lymph nodes and spreads in a pattern resembling tiny, follicle-like structures, it is classified as follicular lymphoma. The designation 'unspecified site' indicates that the specific origin within the lymphatic system has not been identified or documented. This form of lymphoma is typically slow-growing, meaning it progresses over an extended period, often impacting the patient's quality of life rather than causing immediate life-threatening complications.

Causes & Symptoms

Clinical Causes: Genetic mutations: Changes in the DNA of B-cells can lead to abnormal growth. Aging: The risk increases with age, commonly diagnosed in middle-aged or older adults. Certain infections: Some viruses have been associated with increased risk, such as hepatitis C. Chemical exposure: Contact with certain chemicals and pesticides has been linked to a higher risk. Family history: Having relatives with lymphoma or other blood cancers may elevate risk. Immunosuppressive conditions: Conditions or treatments that weaken the immune system might contribute.

Key Symptoms: Swollen lymph nodes: Often painless enlargements in the neck, armpits, or groin. Fatigue: Feeling unusually tired without clear reason. Unexplained weight loss: Significant weight loss over a short period. Fever: Recurrent or persistent fever without infection. Night sweats: Drenching sweating episodes during the night. Itching: Generalized itching without an apparent cause. Abdominal pain or swelling: If the lymphoma involves abdominal lymph nodes or organs. Other signs: Due to varying sites of involvement, symptoms may differ.

Diagnostic & Treatment

Diagnosis Path: Accurate diagnosis involves several steps: - Physical examination to check for swollen lymph nodes. - Blood tests to evaluate overall health and detect abnormal cells. - Imaging studies such as CT scans or PET scans to observe the extent of disease distribution. - Biopsy: The definitive diagnosis is made through extracting a tissue sample from an enlarged lymph node, which is examined microscopically for characteristic follicular patterns. - Immunophenotyping: Tests that analyze proteins on the cell surface to confirm lymphoma type. - Staging procedures to determine how far the disease has spread.

Treatment Protocols: While treatment decisions are individualized based on disease stage and patient health, common options include: - Observation (watchful waiting) for asymptomatic, slow-growing cases. - Chemotherapy regimens aimed at controlling disease progression. - Rituximab: A targeted immunotherapy that helps the immune system attack lymphoma cells. - Radiation therapy: Usually applied in localized disease situations. - Stem cell transplantation: Considered in certain advanced or relapsed cases. - Clinical trials: Participation in studies exploring new therapies may be an option. Management aims to control symptoms, slow disease progression, and maintain quality of life.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C82.80 a billable ICD-10 code?
Yes, C82.80 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C82.80?
Clinical documentation must specify the nature of Other types of follicular lymphoma, unspecified site and any associated comorbidities for accurate reporting.

Cite this Clinical Reference